Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism E-sel inhibitors(Selectin E inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Myeloma | Phase 2 | United States | 30 Jan 2022 | |
Multiple Myeloma | Preclinical | China | 30 Jan 2022 |